Results 231 to 240 of about 198,762 (311)

Programmable nanomotor system responsively and chemotactically captures tumor associated antigens for enhanced <i>in situ</i> cancer vaccine. [PDF]

Mater Today Bio
Song P, Han X, Wang Y, Wang X, Kang Y, Yan J, Zhang H.   +6 more
europepmc   +1 more source

Next‐Generation Surgery: Integrating Artificial Intelligence, Genetic Technologies, Bioengineering and Rehabilitation Into Modern Practices

Exploration, EarlyView.
This graphic abstract depicts the convergence of artificial intelligence, genetic technologies, bioengineering, and rehabilitation as the core pillars of next‐generation surgery. These domains collectively enhance preoperative planning, intraoperative precision, tissue reconstruction, and postoperative recovery, driving a paradigm shift toward ...
Dengxiong Li, Jie Wang, Zhipeng Wang, Ruicheng Wu, Zhouting Tuo, Fanglin Shao, Wenjing Ge, Ziyu Shu, Yubo Yang, Dilinaer Wusiman, Qingxin Yu, Luxia Ye, Alisha Pati‐Alam, Facai Zhang, Koo Han Yoo, Susan Heavey, William C. Cho, Dechao Feng   +17 more
wiley   +1 more source

Enhancing DC cancer vaccine by allogeneic MHC class II expression and Treg depletion. [PDF]

JCI Insight
Seishima N, Becker W, Olkhanud PB, Maeng HM, Lopez-Lago MA, Williams WV, Berzofsky JA.   +6 more
europepmc   +1 more source

Enhancing Optogenetics‐Based Cancer Therapy Via Nanotechnology

Exploration, EarlyView.
Nanotechnology enhances optogenetics‐based cancer therapy through improved delivery systems and non‐invasive optical regulation. It further enables precise and programmable control of optogenetic living therapeutics for localized antitumor responses.
Honggang Shen, Wenzhe Yi, Rongzhang Li, Shuangshuang Hu, Xindi Qian, Dan Yan, Qian Zou, Guanru Wang, Yaping Li   +8 more
wiley   +1 more source

Lung cancer vaccine strategies: exploring the spectrum from traditional to RNA-based platforms. [PDF]

Front Bioeng Biotechnol
Pazoki A, Dadfar S, Alirezaee A, Oksenych V, Haghmorad D.   +4 more
europepmc   +1 more source

Integrating Immunotherapy Into Head and Neck Surgery: Bridging Tumor Biology to Perioperative Decision‐Making, a Review

Head &Neck, EarlyView.
ABSTRACT Objective To provide a comprehensive review of the biological rationale, clinical evidence, and practical perioperative management of immunotherapy for the head and neck surgeon. Summary Background Data Standard treatment for resectable head and neck squamous cell carcinoma (HNSCC) has reached a survival plateau, with over 50% of patients ...
Nicholas Brian Shannon, Bruce Ashford
wiley   +1 more source

A Nanomodulator Enhances Radiotherapy-Induced In Situ Cancer Vaccine by Promoting Antigen-Presenting of Tumor-Associated Macrophage. [PDF]

Adv Sci (Weinh)
Zhao X, Li M, Li J, Han Y, Gong Y, Zhang Z, Shi J, Jin CY, Liu J, Si P.   +9 more
europepmc   +1 more source

Balancing Antigen Loading on Gold Nanoparticles: Implications for Future Cancer Vaccine Strategies. [PDF]

Chemistry
Ghirardello M, Guerreiro A, Bretón C, Compañón I, Zabalza J, Mangini V, Peregrina JM, Bernardes GJL, Corzana F.   +8 more
europepmc   +1 more source

Promising future of breast cancer vaccine asking for multidisciplinary collaboration: a literature review. [PDF]

Front Cell Dev Biol
Zhang Z, Li M, Zhang L, Wang M, Liu D, Tang S, Li Y, Fang X, Ren S.   +8 more
europepmc   +1 more source

Influenza and Human Papillomavirus Vaccine Utilisation in Vulnerable Urban Youth in Edmonton, Alberta, Canada

The International Journal of Health Planning and Management, EarlyView.
ABSTRACT Introduction This project explores influenza and human papillomavirus (HPV) vaccine utilisation among a multi‐ethnic group of youth (aged 11–23 years) in Edmonton, Alberta, Canada. Method Using a cross‐sectional design and purposive sampling, influenza vaccine utilisation over 3 years was assessed via questionnaire.
Sarah Deck, Se Lim Jang, Rachel Harris, Fariba Kolahdooz, Moutasem Zakkar, Sangita Sharma   +5 more
wiley   +1 more source